181 related articles for article (PubMed ID: 15550927)
1. Adeno-associated virus-mediated delivery of a mutant endostatin suppresses ovarian carcinoma growth in mice.
Subramanian IV; Ghebre R; Ramakrishnan S
Gene Ther; 2005 Jan; 12(1):30-8. PubMed ID: 15550927
[TBL] [Abstract][Full Text] [Related]
2. Recombinant adeno-associated virus 2-mediated antiangiogenic prevention in a mouse model of intraperitoneal ovarian cancer.
Isayeva T; Ren C; Ponnazhagan S
Clin Cancer Res; 2005 Feb; 11(3):1342-7. PubMed ID: 15709207
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus-mediated delivery of a mutant endostatin in combination with carboplatin treatment inhibits orthotopic growth of ovarian cancer and improves long-term survival.
Subramanian IV; Bui Nguyen TM; Truskinovsky AM; Tolar J; Blazar BR; Ramakrishnan S
Cancer Res; 2006 Apr; 66(8):4319-28. PubMed ID: 16618757
[TBL] [Abstract][Full Text] [Related]
4. Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin.
Zhang X; Xu J; Lawler J; Terwilliger E; Parangi S
Clin Cancer Res; 2007 Jul; 13(13):3968-76. PubMed ID: 17606731
[TBL] [Abstract][Full Text] [Related]
5. Potent antitumour activity of the combination of HSV-TK and endostatin armed oncolytic adeno-associated virus for bladder cancer in vitro and in vivo.
Pan JG; Zhou X; Zeng GW; Han RF
J Surg Oncol; 2012 Mar; 105(3):249-57. PubMed ID: 21953122
[TBL] [Abstract][Full Text] [Related]
6. Improved biological activity of a mutant endostatin containing a single amino-acid substitution.
Yokoyama Y; Ramakrishnan S
Br J Cancer; 2004 Apr; 90(8):1627-35. PubMed ID: 15083196
[TBL] [Abstract][Full Text] [Related]
7. [Human endostatin antiangiogenic gene therapy mediated by recombinant adeno-associated virus vector in nude mouse with endometriosis].
Sun JJ; Yin LR; Mi RR; Ma HD; Guo SJ; Shi Y; Gu YJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):45-50. PubMed ID: 20367926
[TBL] [Abstract][Full Text] [Related]
8. [Gene therapy of bladder cancer by using recombinant adeno-associated virus-endostatin: experiments in vitro and in vivo].
Lu BX; Han RF; Tang Y; Han YZ; Li SZ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):802-5. PubMed ID: 17565858
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy delivery of endostatin enhances the treatment efficacy of radiation.
Shi W; Teschendorf C; Muzyczka N; Siemann DW
Radiother Oncol; 2003 Jan; 66(1):1-9. PubMed ID: 12559515
[TBL] [Abstract][Full Text] [Related]
10. Suppression of bladder cancer growth by adeno-associated virus vector-mediated combination of HSV-TK and endostatin in vitro.
Pan JG; Luo RQ; Zhou X; Han RF; Zeng GW
Clin Lab; 2013; 59(9-10):1077-89. PubMed ID: 24273931
[TBL] [Abstract][Full Text] [Related]
11. Adeno-associated virus 2-mediated antiangiogenic cancer gene therapy: long-term efficacy of a vector encoding angiostatin and endostatin over vectors encoding a single factor.
Ponnazhagan S; Mahendra G; Kumar S; Shaw DR; Stockard CR; Grizzle WE; Meleth S
Cancer Res; 2004 Mar; 64(5):1781-7. PubMed ID: 14996740
[TBL] [Abstract][Full Text] [Related]
12. [Adeno-associated virus-mediated expression of human endostatin and its biological activity in vitro].
Li XH; Li XP; Li G; Liu X
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):651-4. PubMed ID: 15958300
[TBL] [Abstract][Full Text] [Related]
13. Potent antitumor activity of the combination of HSV-TK and endostatin by adeno-associated virus vector for bladder cancer in vivo.
Pan JG; Luo RQ; Zhou X; Han RF; Zeng GW
Clin Lab; 2013; 59(9-10):1147-58. PubMed ID: 24273940
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of corneal neovascularization with endostatin delivered by adeno-associated viral (AAV) vector in a mouse corneal injury model.
Lai LJ; Xiao X; Wu JH
J Biomed Sci; 2007 May; 14(3):313-22. PubMed ID: 17373573
[TBL] [Abstract][Full Text] [Related]
15. Adeno-associated virus-mediated delivery of kringle 5 of human plasminogen inhibits orthotopic growth of ovarian cancer.
Bui Nguyen TM; Subramanian IV; Xiao X; Nguyen P; Ramakrishnan S
Gene Ther; 2010 May; 17(5):606-15. PubMed ID: 20200565
[TBL] [Abstract][Full Text] [Related]
16. Suppression of bladder cancer growth in mice by adeno-associated virus vector-mediated endostatin expression.
Pan JG; Zhou X; Zeng GW; Han RF
Tumour Biol; 2011 Apr; 32(2):301-10. PubMed ID: 21052889
[TBL] [Abstract][Full Text] [Related]
17. Addition of integrin binding sequence to a mutant human endostatin improves inhibition of tumor growth.
Yokoyama Y; Ramakrishnan S
Int J Cancer; 2004 Oct; 111(6):839-48. PubMed ID: 15300795
[TBL] [Abstract][Full Text] [Related]
18. [Research of the anti-tumor effect of human endostatin mediated by recombinant adeno-associated virus].
Lu GQ; Zha YY; Wu XB; Yang JG; Zhang XY; Fu M; Liang X; Wu M; Lin C
Ai Zheng; 2002 Dec; 21(12):1314-8. PubMed ID: 12520738
[TBL] [Abstract][Full Text] [Related]
19. AAV-P125A-endostatin and paclitaxel treatment increases endoreduplication in endothelial cells and inhibits metastasis of breast cancer.
Subramanian IV; Devineni S; Ghebre R; Ghosh G; Joshi HP; Jing Y; Truskinovsky AM; Ramakrishnan S
Gene Ther; 2011 Feb; 18(2):145-54. PubMed ID: 20844568
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human nasopharyngeal carcinoma growth and metastasis in mice by adenovirus-associated virus-mediated expression of human endostatin.
Li XP; Li CY; Li X; Ding Y; Chan LL; Yang PH; Li G; Liu X; Lin JS; Wang J; He M; Kung HF; Lin MC; Peng Y
Mol Cancer Ther; 2006 May; 5(5):1290-8. PubMed ID: 16731762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]